“…All animal procedures were approved by the University of Colorado Institutional Animal Care and Use Committee or the Institutional Animal Care and Use Committee of the Cleveland Clinic Foundation. Mouse lines used were PLP null mice (Pende et al, 1994;Klugmann et al, 1997;Yuan et al, 1998;Deng et al, 2003Deng et al, , 2004Káradó ttir et al, 2005;Salter and Fern, 2005;Narayanan et al, 2009), GluR2null mice (Iihara et al, 2001;Narayanan et al, 2009;Tyler et al, 2009;Wahl et al, 2014), and ␣v integrin heterozygous mice (Bader et al, 1998;Fyffe-Maricich et al, 2011Ishii et al, 2012). All lines were crossed with PLP-EGFP mice (Barres et al, 1994;Ahlgren et al, 1997;Mallon et al, 2002;Huang et al, 2011), in which the Plp1 promoter drives EGFP in cells of the oligodendroglial lineage.…”